2017 May;13(5):855861
Dziki temu agonici GLP-1 s szczeglnie zalecani u chorych z cukrzyc i jednoczenie nadwag lub otyoci wytyczne podkrelaj ich przewag nad lekami powodujcymi przyrost masy ciaa (Systematic review of the efficacy and safety of GLP-1 receptor agonists in the treatment of patients with type 2 diabetes mellitus)
It does not guarantee individual outcomes, clinician approval, or specific results
Praise for Becky Dorner & Associates A Comprehensive Review: Managing Type 1 Diabetes Self-Study Course Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDCES The Dietitians Guide to Nutrition Assessment Course Katy Adams, MDA, RD, CSG, LD Aimee Shea, MPH, RDN, CCMS, LD Reducing Dementia Risk: New Research and Practical Applications Doreen Rodo, MEd, RDN, LD Nutrition Management of Food Allergies Course Lisa Cooperman, MS, RDN Diabetes and Pregnancy: A Nutrition Update Casey Seiden, MS, RDN, CDCES